Search Within

Kendrick Tang

Formats
  1. Meeting Abstract (3)
  2. Journal Article (2)
Groups
  1. Breast Medicine Service (5)
  2. Department of Medicine (5)
  3. Solid Tumor Oncology Division (5)
  4. Biostatistics Service (4)
  5. Epidemiology and Biostatistics (4)
  6. Medical Physics (3)

More Groups

People
  1. Andrew Seidman (5)
  2. Sujata Patil (4)
  3. Andrei Holodny (3)
  4. Heiko Schoder (3)
  5. John Humm (3)
  6. Kathryn Beal (3)

More People

Years
  1. 2021 (1)
  2. 2019 (3)
  3. 2018 (1)
Publications
  1. Breast Cancer Research and Treatment (1)
  2. Cancer Research (1)
  3. Clinical Cancer Research (1)
  4. Journal of Clinical Oncology (1)
  5. Neuro-Oncology Advances (1)
Publishers
  1. American Association for Cancer Research (2)
  2. American Society of Clinical Oncology (1)
  3. Oxford University Press (1)
  4. Springer (1)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative study of FLT-PET brain imaging
    Journal Article

    Morikawa, A.; Grkovski, M.; Patil, S.; Jhaveri, K. L.; Tang, K.; Humm, J. L.; Holodny, A.; Beal, K.; Schòˆder, H.; Seidman, A. D.
    Breast Cancer Research and Treatment (2021)

    Fulltext@MSK | Save
  • A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative FLT-PET brain imaging study in patients receiving WBRT +/- sorafenib
    Meeting Abstract

    Morikawa, A.; Grkovski, M.; Patil, S.; Jhaveri, K.; Tang, K.; Humm, J.; Holodny, A.; Beal, K.; Schoder, H.; Seidman, A.
    Neuro-Oncology Advances (2019)

    Fulltext@MSK | Save
  • A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative study of FLT-PET brain imaging in patients receiving WBRT with or without sorafenib
    Meeting Abstract

    Morikawa, A.; Jhaveri, K.; Grkovski, M.; Tang, K.; Humm, J. L.; Holodny, A.; Beal, K.; Schoder, H.; Seidman, A. D.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Phase I study of intermittent high-dose lapatinib alternating with capecitabine for HER2-positive breast cancer patients with central nervous system metastases
    Journal Article

    Morikawa, A.; de Stanchina, E.; Pentsova, E.; Kemeny, M. M.; Li, B. T.; Tang, K.; Patil, S.; Fleisher, M.; Van Poznak, C.; Norton, L.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Phase I study of intermittent high-dose lapatinib alternating with capecitabine for HER2-positive breast cancer with central nervous system metastases
    Meeting Abstract

    Morikawa, A.; Pentsova, E.; Kemeny, M.; Patil, S.; Li, B. T.; Tang, K.; Fleisher, M.; Van Poznak, C. H.; Norton, L.; Seidman, A. D.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save